Treatment Strategies in
Burn Wounds: An Overview
Deependra Singh, Mukesh
K. Nag, Satish Patel, Madhulika
Pradhan, Shikha Shrivastava, SJ Daharwal, Manju
R. Singh*
University
Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur, Chhattisgarh, India
ABSTRACT:
Wound
healing involves a regulated sequence of cellular activity. These activities
provide the foundation for the mechanisms of wound repair. Successful wound
care involves optimizing local and systemic conditions in combination with an
ideal wound healing environment. The basic steps of wound management are prevention of wound
contamination, debridement of dead and dying tissue, removal of debris and
contaminants, provision of adequate wound drainage, promotion of a viable
vascular bed and selection of an appropriate method of closure. A wide variety
of preparations and remedies of non-organic, organic, biogenic, and phytogenic origin have been devised and used in the topical
treatment of burns. Many different
strategies have been developed to influence this wound environment to provide a
pathogen-free, protected, and moist area for healing to occur. This review
discusses the physiology, type and management of burn wounds and future
directions for this field.
1. INTRODUCTION
A burn is a type of injury to skin caused
by heat, electricity, chemical, light, radiation or friction. Burn patients
often require multiple surgical episodes and dressing changes followed by
prolong rehabilitation and victim can be left with lifelong dysaesthetic
scarring and potential dysfunction. Most burn affects only the skin. In case of
severe burns deeper tissues like bone, muscle and blood vessels can also be
wounded1.
Burn wound injuries to the skin result in
loss of its protective function as a barrier to the microorganism leading to
the high risk of infection. Thus burn wound patient face high morbidity than
mortality because of the large uncovered burns getting infected; healing of
wound takes place long period of dressing, leading to deformities and
contractures. Managing burn injuries properly is important because they are
painful and can cause disabling scarring, exclusion of affected parts or even
death in severe cases. Problems such as infection, electrolyte imbalance, shock
and respiratory suffering may occur. The treatment of burn includes removal of
dead tissues (debridement), dressing of wound, fluid recovery, antibiotics
administration and skin grafting2.
2. CLASSIFICATION OF WOUNDS
A
wound is the disruption of the integrity of anatomical tissues caused by
exposure to any factor. Wounds are examined under two groups:
2.1 Closed
Wounds: This group includes contusion, hematoma and abrasion. Contusion
involves the injury of soft tissues, deep tissue layers and small blood
vessels, resulting in their separation, but the skin anatomy remains unbroken. Oedema, and in later periods, atrophy and defective
pigmentation are observed in wound and the healing is delayed. Vessel rupture
due to vessel damage is called hematoma and wounds such as scrapes are termed
abrasions.
Healing process is extremely painful
because this type of wound involves harm to sensory nerves and the wound can
easily become infected.
Closed wounds are as dangerous
as open wounds. The types of closed wounds are:
·
Contusions generally identified as bruises, caused by a
blunt force trauma those damages tissue under
the skin.
·
Hematomas,
also called a blood tumour, caused by damage to
a blood vessel that
in turn causes blood to
collect under the skin.
2.2 Open Wounds: This group includes lacerations,
cutting-pricking tool wounds, gunshot wounds, surgical wounds and metabolic
wounds. Wounds excluding for lacerations effect serious damage to tissues below
the skin. In laceration type wounds, skin and subcutaneous tissue have been
destroyed, but deep tissues remain healthy. The integrity of tissues anatomy is
injured in cutting pricking tool wounds with no any tissue damage at the edges
of the wound3.
Open wounds can be classified on
the basis of thing that caused the wound. The types of open wound are:
·
Incisions wounds created by
a clean, sharp-edged object such as a knife, razor, or glass splinter.
·
Lacerations, irregular
tear-like wounds caused by some blunt trauma.
Lacerations and incisions may appear regular) or irregular. The term laceration is commonly misused
in reference to incisions.
·
Abrasions, superficial wounds in which the
epidermis is scraped off. Abrasions are frequently caused by a sliding fall
onto a rough surface.
·
Puncture wounds is generated
by an object puncturing the skin
like nail or needle.
·
Penetration wounds, caused by an article such
as a knife entering and coming out from the skin.
·
Gunshot wounds, caused by
a bullet or
related shot driving into or through the body. There may be two wounds, one at
the site of entry and one at the site of exit, generally referred to as a
"through-and-through."
3. WOUNDS ARE ALSO CLASSIFIED ACCORDING TO
TISSUE LOSS
3.1 Wounds with
Tissue Loss: These types of wounds involve damage or loss in some or all of the
skin layers. Healing occurs via filling
of the wound area by granulation tissue typically growing from the base of a
wound. According to tissue loss they are collected in two groups. In
superficial wounds, the whole epidermis and papillary layer of the dermis are
damaged. In full-thickness wounds epidermis, the entire the layers of the
dermis and subcutaneous tissue are also damaged4.
3.2 Wounds
without Tissue Loss: These kinds of wounds occur as a result of
tissue crushing. The severity of bleeding occurring in tissue varies according
to the condition of the wound. Tissues exposed to this kind of wound heal after
granulation tissue formation in minimal level in first phase of healing process5.
4.
CLASSIFICATION OF BURNS WOUNDS
Burn wound
produce when skin or organs are damaged by an electrical current, heat,
chemical or flammable agent effect6.
Burns
can be classified into 4 groups based on depth and the affected skin layers:
4.1
First-degree burns
First-degree
burns generally occur as a result of short term heat or flame contact or
long-term exposing to intense sunlight. Only the outer layer of the epidermis
and Stratum corneum
are damaged in this type of burn, and there is no damage in the dermis.
First-degree burn areas are characterised by slight oedema. At this stage the skin begins to dry and it heals
within a week7.
·
Limited to the epidermis
·
Mild discomfort
·
Commonly treated on outpatient basis
4.2
Second-degree burns
These
types of burns are deeper than first-degree burns and necrosis spread into the
dermis. Damage covers the entire epidermis and some part of dermis. The wound
is clinically characterised by pain and erythema. The healing depends on the deepness of skin
damage and formation of infection. Generally, second-degree burns repair
suddenly in a short period if infection does not occur. If infection occurs in
the wound, it can easily convert to third degree burn. The burns in this group
may be divided into two categories, termed superficial and deep dermal
second-degree burns8.
Superficial Second Degree Burns: These occur due to short period
contact with flame or hot liquids. Generally, the upper portion of the Stratum germinativum
is damaged in superficial second-degree burns. Because of the leakage of
liquid plasma from the burned area surface is generally humid. Recovery usually
occurs within 3-4 weeks with zero or very mild scarring9.
·
Involves the epidermis and external part of the dermis
·
Often seen with scalding injuries
·
Presents with blister formation and typically blanches with
pressure
·
Sensitive to light touch or pinprick
Deep Dermal Burns: It is occur due to contact with chemicals such as
flame, hot liquids or acids, or exposure to high electrical current. In these
types of burns, epidermis is completely burned, which is extends to the Stratum germinativum
damage and the base section of the dermis. Re-epithelialisation
time depends on dermis degradation, the burnt hair follicles amount and sweat
glands, and the infected areas width. It generally closes within 2 months if
the wound is properly preserved10.
·
Involves the epidermis and the majority of the dermis
·
A smaller amount sensitivity to light touch and pinprick than
superficial form
4.3
Third-degree burn
These
kinds of burns result from hot water, fire and prolonged contact with
electrical current. The wound area exhibits tautness and brightness as the
elasticity of the skin is lost, causing abnormal shrinkage. In such cases, all
structures within the skin sustain damage. The dermis and subcutaneous fat are
destroyed as a result of coagulation necrosis. Thrombosis occurs in vessels
under the skin. Increased capillary permeability and oedema
is much higher in third degree burns than second-degree burns. This event is
usually associated with suppuration. Capillary bundles and fibroblasts are organised in granulation tissue under scar. If the burn
affects subcutaneous fat, healing can take much longer. Burn affecting the
muscle causes increasing in degradation of red blood cells. The care of
third-degree burns requires removing scar tissue and covering the wound with a
graft. If grafting is not carried out, a thick layer of granulation is shaped
and the contraction of the area follows it. At this stage, re-epithelialisation, slightly, occurs on the edge of wound
granulation is soft, can be infected and healing continues over several months.
Permanent deep scars in the skin occur following healing in these kinds of
wounds and surgical intervention is usually required to restore normal
appearance11.
·
Involves epidermis, and the entire layers of dermis, extended to
subcutaneous tissue
·
Appears dry, leathery, and insensate
·
Can be difficult to differentiate from deep partial-thickness
burns
·
Usually found when patient’s clothes caught on fire
·
Generally require transfer to burn surgeon for skin grafting to
heal.
4.4
Fourth-degree burns
Fourth degree burns is a result of
high-voltage electric injury or severe thermal burns, which requires hospital
admission. This refers to the carbonization of burned tissues (Table 1).
5. WOUND HEALING
PROCESS
The wound healing process is a series of
independent and overlapping stages. In these stages will both cellular and
matrix compounds work to re-establish the integrity of damaged tissue and
replacement of lost tissue. These overlapping series can be classified in five
stages:
5.1 Haemostasis: the first response to injury is bleeding. Bleeding is an
effective way to wash out bacteria that are on the surface of skin. Afterwards,
bleeding activates haemostasis stage that is
initiated by clotting factors. The clot dries out and creates a hard surface
over the wound that protects tissues underlying.
5.2 Inflammation: this stage starts almost at
same time as haemostasis. It occurs from between few
minutes to up to 24 minutes after injury. In this stage histamine and serotonin
are released into wound area and activate phagocytes to enter the wound area
and engulf dead cells.
5.3 Migration: in this stage the
reestablishment of wound begins. The epithelial cells and fibroblasts move into
the injured area and grow rapidly under the hard scab to replace the damaged
tissue.
5.4 Proliferation: this stage has three
characteristics. First, the granulation tissue is formed by growth of
capillaries. Lymphatic vessels enter into wound in to second stage and the
third one, synthesis of collagen starts providing form and strength to the
injured tissue.
5.5 Maturation: in this stage, the shape of the
final scar is determined by formation of cellular connective tissue and
strengthening of the new epithelium12.
TABLE1:
Degrees of burn injury.
|
Names |
Layers involved |
Appearance |
Texture |
Sensation |
Time to healing |
|
Superficial (First degree) |
Epidermis |
Dry |
2-3 days |
||
|
Superficial partial thickness
(Second degree) |
Extends into superficial
(papillary) dermis |
Red with clear blister. Blanches with pressure |
Moist |
Painful |
1-2 weeks |
|
Deep partial thickness (Second
degree) |
Extends into deep (reticular)
dermis |
Red-and-white with bloody
blisters. Less blanching. |
Moist |
Painful |
3-4 weeks |
|
Full thickness (Third degree) |
Extends through entire dermis |
Stiff and white/brown |
Dry, leathery |
Painless |
Prolonged and incomplete |
|
Fourth degree |
Extends through skin, subcutaneous tissue and into underlying muscle and bone |
Black; charred with eschar |
Dry |
Painless |
Requires excision |
6. CAUSES OF BURN
Burns can cause by a broad variety of
substance and external sources such as contact with electricity, chemicals, friction,
radiation and heat.
6.1 Chemical: Most chemicals that cause
chemical burns are strong acids or bases. Corrosive chemical compounds such as
sodium hydroxide and sulphuric acid causes chemical
burns. Hydrofluoric acid is able to damage to the bone and some time burns not
immediately apparent. Depending on time of contact, potency of the material,
and other factors, chemical burns can be either first, second, or third degree
burns.
6.2 Electrical: Electrical burns are caused by
an electric shock. Common occurrence of electrical burns comprises workplace
injuries, defibrillated or cardioverted without a
conductive gel. Lightning is also a rare cause of electrical burns.
6.3 Radiation: Radiation burns are caused by
prolonged exposure to UV light, radiation therapy, sunlamps, radioactive
fallout, and X-rays. Most common burn related with radiation is sun exposure,
particularly two wavelengths UVA and UVB, the latter being more dangerous.
6.4 Scalding: Hot liquids (water or oil) or
gases (steam) causes scalding, it mainly occure from
contact to high temperature tap water in baths or showers. When extremity is
held under the surface of hot water immersion scald is created, and it is a
common typr burn seen in child abuse. A blister is
formed in the skin filled with fluid, which is the result of body’s reaction to
the heat and the subsequent inflammatory reaction. Top of the blister is dead
and the fluid contains toxic inflammatory substances. Normally scald burns are
first or second degree burns, but due to prolonged contact it can be third
degree burns.
7. PATHOPHYSIOLOGY OF BURN WOUND
The pathophysiology
of the burn wound is related to the initial distribution of heat onto the skin,
which is a function of both the temperature and the exposure time i.e. a high
temperature for a short time may cause the same tissue damage as a lower
temperature for a longer time. Three zones of histopathological
injury: coagulation, stasis and hyperaemia. The zone
of coagulation is comprised of eschar or necrotic
tissue and is closest to the heat source. This is surrounded by the zone of
stasis, where there is only moderate tissue damage, but slow blood flow and oedema due to capillary leakage and cell membrane
disruption. Poor blood flow in this zone may lead to local tissue ischemia and
further necrosis. Surrounding the zone of stasis is the zone of hyperaemia, in which cell damage is minimal and blood flow
gradually increases resulting in early spontaneous recovery13.
7.1 Pathogenesis of Burn Wound Conversion
Burn wound progression is complex and
caused by additive effects of inadequate tissue perfusion, free radical damage,
and systemic alterations in the cytokine milieu of burn patients, leading to
protein denaturation and necrosis. Fundamental
inferences, infection, tissue desiccation, impaired wound perfusion, oedema, age and metabolic derangements play important
roles.
The pathogenesis of burn wound conversion
is related to a multitude of factors, many of which are related to the presence
of vasoactive and inflammatory
mediators in higher-than-normal concentrations. The role of vasoconstriction is
also very important in burn wound conversion. Thus an imbalanced ratio of vasodilatory and vasoconstrictive
prostanoid can threaten viability of tissue in zone
of stasis. Vasodilatation, too, has been
implicated. Up-regulation of inducible nitric oxide synthase
may produce peripheral vasodilation that sets off an inflammatory cascade detrimental to the survival of
threatened tissue in the zones of stasis and hyperaemia. Up-regulation of transcription factor nuclear
factor results in increased downstream production of many inflammatory
cytokines. In addition, nitric oxide may react to produce per- ox nitrite, an
oxygen free radical that causes additional tissue damage. Free radical injury
to the zones of stasis and hyperaemia may be involved
in the pathogenesis of burn wound conversion. In the setting of acute burns, neutrophil activation and xanthine
oxidase activity generate oxygen radicals such as
hydrogen peroxide and superoxide. Concomitant decreases in superoxide
dismutase, catalase, and glutathione, α-tocopherol, and ascorbic acid levels impair the body’s
antioxidant mechanisms.
Another factor in burn wound progression
may be linked to hypo-perfusion secondary to oedema-related
fluid shift. Prostaglandins, histamine, and bradykinin increase in-transvascular
permeability and promote the passage of fluid
in interstitial spaces. As such, local oedema
translates into both local and systemic fluid
shifts that exacerbate hypo-perfusion in vulnerable tissue, specifically
in the zones of stasis and hyperaemia. Micro
thrombosis of viable tissue proximal to frankly necrotic tissue appears to be
important. Elevated bradykinin levels not only
increase vascular permeability but also act to promote coagulation. In
combination with the pro-coagulant properties of thermal energy, bradykinin may stimulate micro thrombosis in the zone of
stasis and, as such, contribute to the progression of superficial
burns to deeper ones14.
8. FACTORS AFFECTING BURN WOUND CONVERSION
8.1 Local Factors
Several factors act locally to predispose
partial thickness burns to progress to deeper wounds. Most notable are
infection, tissue desiccation, collateral wound oedema,
and circumferential Escher in the extremities. Bacterial infection contributes
to the process and is decreased by topical antimicrobial agents. In a
retrospective study of 342 patients with 10%–50% total-body-surface-area burns,
demonstrated that topical 1% silver sulfadiazine decreased both the conversion
rate and the healing time of deep partial-thickness burns. The bacterial load
of predominant surface microorganisms, specifically
Staphylococcus aureus, Pseudomonas species, and Klebsiella species, was also decreased. Silver-coated
barrier dressings have also been shown to be effective in burns closed with
cultured skin substitutes (Table 2).
Oedema, desiccation, and
circumferential eschar are local factors that
increase rate of burn wound progression by decreasing tissue perfusion. Local hyperaemia and desiccation compromise perfusion via shifts
in intravascular and interstitial fluid
volumes. Both processes decrease intracellular fluid
volumes, altering homeostasis in a manner that ultimately decreases
intravascular volume and inhibits oxidative metabolism of partially burned
tissue. Circumferential eschar in the extremities
acts mechanically, compromising distal tissue perfusion when escharotomy is delayed15.
8.2 Systemic Factor
Systemic factors can be considered as those
that impair wound perfusion, those that predispose to infection, those related
to metabolic derangements, and those that are related to general health status.
Impaired wound perfusion often occurs secondary to shock, hypoxia resultant
from pulmonary insufficiency, and massive wound sepsis. Conversion of partial-
to full-thickness burns is hastened when fluid
resuscitation fails to provide adequate flux,
or perfusion, to burn wound (Table 3). Similarly, restoring and maintaining
perfusion pressures maximally oxygenates injured and non-injured tissues and,
as such, promotes spontaneous healing while minimizing wound conversion and
bacterial colonization16.
9. BURN WOUND MANAGEMENT
Injuries caused by severe burn injuries
result in significant disability and death. The final aim of burn management
and therapy is wound healing and epithelisation as
soon as possible in order to prevent infection and to reduce functional
aesthetic after use. The goal of burn treatment is to provide the most rapid
possible healing of surface burns and to speed up the surgically provided
restoration of lost skin in deep burns. The local conservative treatment of
burn injuries is of major importance. Treatment of patients with superficial
damage is always conservative. In deep burns, local treatment is used to
prepare wounds for surgery and to create conditions for the non-rejection of
auto dermotransplants and full-thickness grafts.
Recent advances in clinical care have reduced morbidity and mortality. A wide
variety of preparations and remedies of non-organic, organic, biogenic, and phytogenic origin have been devised and used in the topical
treatment of burns17.
TABLE 2: Local
factors that may contribute to burn wound conversion
|
Proposed mechanism |
Contributing factors |
Tissue level consequences |
|
1.Impaired wound perfusion 2. Infection
predisposition 3. Metabolic
derangements 4. General
health status |
Shock, hypoxia, massive sepsis
wound, inadequate fluid
resuscitation Decreased IL-12,
increased TH-2 cells and decreased C3 conversion. Depressed
glucose uptake Depressed lavtate release Increased
metabolic need Advanced age Vascular
pathology, including atherosclerosis, coagulopathy,
and peripheral vessel disease Diabetes
mellitus Immunosuppression |
Bacterial
virulence factor causing cell death. Inflammation
causing cell death. Cytokine
alteration increase susceptibility to wound infection. Metabolic
insufficiency Less robust healing, immune function, and
tissue perfusion |
TABLE 3: Systemic
factors that may contribute to burn wound conversion
|
Pathophysiological changes |
Proposed mechanism |
Tissue level consequences |
|
1. Infection 2. Edema 3. Tissue
desiccation 4.
Circumferential eschar in the extremities |
Overwhelms
metabolic capacity of tissue Fluid shifts
decrease intracellular and intravascular fluid,
thereby there by compromising cellular respiration. Decreased
intracellular and intravascular fluid
compromises cell Mechanically
decreases vessel caliber, compromising flow
to distal tissueular respiration |
Bacterial
virulence factors causing cell death Decreased tissue
perfusion Decreased tissue
perfusion Decreased tissue
perfusion |
9.1 Initial Wound Management
The basic steps of wound management are
prevention of further wound contamination, debridement of dead and dying
tissue, removal of debris and contaminants, provision of adequate wound
drainage, promotion of a viable vascular bed and selection of an appropriate
method of closure. The aim of any therapy is to facilitate wound healing
mechanisms by providing a warm, clean environment and an adequate blood supply.
9.1.1 Wound debridement
Debridement is the removal of devitalised tissue from a wound to encourage rapid onset of
the proliferative phase of wound healing. Wound debridement can be surgical,
enzymatic, mechanical or hydrodynamic. Enzymatic debridement agents may be
indicated for wounds where adequate surgical debridement is not possible or in
locations such as distal limbs where excessive debridement of healthy tissues
should be avoided. Properly used enzymatic agents dissolve wound exudates,
coagulum and necrotic debris without directly harming living tissue. Bacteria
lose their protective proteinaceous and nuclear
material and are exposed to the effects of cellular and humoral
immunity and antimicrobial agents. Advantages include the ability to apply
enzyme solutions without anaesthesia and to use them
in areas with important structures such as nerves and tendons. Wet saline
bandages over the wound will enhance the enzymatic action. Disadvantages
include expense, time required for adequate debridement, frequency of dressing
changes, and potentially insufficient debridement of burned skin, necrotic bone
and connective tissue 18. Singh and co-workers developed carrier
system for Serratiopeptidase delivery. They reported
that this novel carrier system showed controlled-release delivery system for
peptide drug19.
9.2 Topical burn wound treatment
Because injury disrupts the protective
barrier function of the skin dressing are needed to protect the body against
environmental flora. Burn dressing also protects evaporative heat loss. The
ideal burn wound dressing would be inexpensive and comfortable and would not
require frequent changing. Daily dressing changing allows the burn care
provider not only to apply clean dressings but also to clean the wounds and debride fragments of eschar and
devitalized tissue. Selection of appropriate dressing for a given wound is
governed by the specific goals of management. In superficial wounds, the aim is
always to generate moist environment that will increase the epithelialization
process. This is achieved by applying ointment or lotion. With partial
thickness or full thickness wounds it is necessary to include agents that
protect against microbial colonization20.
9.2.1 Wound dressing
The purpose of bandaging is to minimise haematoma and oedema formation, reduce dead space, protect against
additional contamination or trauma, absorb drainage, establish adequate oxygen
tension, maintain a moist environment and minimise
motion (Table 4). A moist environment encourages angiogenesis which is
essential for the delivery of cellular components for wound healing21.
9.2.1.1 The following characteristics are
required for ideal wound and burn dressing
• Ease of
application
• Bioadhesiveness to the wound surface
• Sufficient
water vapour permeability
• Easily sterilised
• Inhibition of
bacterial invasion
• Good mechanical
strength and elasticity
• Compatible with
therapeutic agents
• Optimum oxygen
permeability
•
Biodegradability
• Non-toxic
Table 4. Type of
dressings used in burn22
|
S.No. |
Type of
dressings |
Uses |
|
1. |
Retention
Dressing |
Low profile dressings
used to assist adherence of other dressings or as primary dressing for
superficial (minimally exudating) wounds |
|
2. |
Hydrocolloids |
Low profile,
waterproof, highly conformable, wound interactive dressing |
|
3. |
Alginates |
Haemostatic dressing
for moderately exudating or bleeding/oozing wounds |
|
4. |
Foams |
Used to control
moderate to highly exudating wounds or protect
fragile healed or almost healed area |
|
5. |
Hydrogels |
Used to maintain
or introduce moisture into a wound. May be used to protect and hydrate
exposed tendons or bone. |
|
6. |
Absorbent
dressing |
Used to mop up
heavily exudating wounds |
|
7. |
Non-stick
dressing |
Used as
anti-shear layers in dressing systems |
|
8. |
Wound Growth
Factor Impregnated Dressings |
Low profile,
interactive, dressings / films which are often used acutely to reduce /
prevent wound progression |
|
9. |
Biological
dressing |
Preparations
used to provide another option for introducing growth factors onto the wound
e.g. xenograft. |
|
10. |
Films |
Low profile,
waterproof, highly conformable, adhesive dressing. |
9.2.2 Topical Antimicrobial for Burn Wound
Topical antimicrobial
preparations have been particularly applied to prevent and treat burn infections
compared to other traumatic, surgical and medical indications which could be
susceptible to infection. Many of the agents are designed to be used prophylactically to prevent infection developing, while
others are designed to kill the actually microbial cells that are proliferating
within the burn when an infection has developed (Table 5). Many of these
topical agents are applied onto the surface of the burn, if they are designed
to be actively microbicidal, consideration must be
given to the degree which the agents will penetrate into the burned infected
tissue to reach the microbial cells that have invaded23,24. We can measured the
extent to which several agents (gentamicin sulphate, mafenide acetate, nitrofurazone, povidone-iodine,
silver nitrate, and silver sulfadiazine) penetrated through burn eschar25,26,27.
Table 5. Antimicrobial agents used in burn
care
|
S.no. |
Antimicrobial
agent |
Antimicrobial
coverage |
|
1. |
Bcitracin (Bacillus
subtilis) |
Gram
+ bacteria |
|
2. |
Polymyxin B sulphate (Bacillus
polymyxa) |
Gram
- bacteria |
|
3. |
Neomycin
and other aminoglycoside (Streptomyces fradie) |
Gram
+ bacteria |
|
4. |
Mupricin(P flourescens) |
Anti
MRSA |
|
5. |
Nystatin (Streptomyces noursei) |
Antifungal |
|
6. |
Mafenide acetate |
Broad
spectrum antibacterial |
|
7. |
Neosporin |
Broad
spectrum antibiotic |
|
8. |
Nitrofurazone |
Gram+,
Gram- |
|
9. |
Povidone iodine |
Gram
+,Gram-, yeast |
|
10. |
Gentamicin |
Gram
- |
|
11. |
Clotrimazole |
Yeast,
Fungi |
|
12. |
Xeroform |
Gram+,
Gram -,yeast |
|
13. |
Repithel |
Gram+,Gram -,Yeast |
|
14. |
Scarlet
red |
Gram
+, Gram - |
|
15. |
Ciclopirox |
Yeast,
Fungi |
|
16. |
Chlorhexidinedigluconate |
Gram+,
Gram-Yeast, Fungi |
9.2.3 Antimicrobial peptide (AMP)
The term
antimicrobial peptides refer to a large number of peptides found among all
classes of life possessing both antibacterial and antifungal activities. They
have been shown to kill Gram-negative and Gram-positive bacteria (including
strains that are resistant to conventional antibiotics), mycobacteria
(including Mycobacterium tuberculosis), enveloped viruses, and fungi. Besides
acting as endogenous antibiotics AMPs also participate in multiple aspects of
immunity 28,29,30. So unlike the majority of conventional
antibiotics the antimicrobial peptides also have the ability to enhance
immunity by functioning as immuno-modulators. AMPs
are divided into heterogeneous groupings on the basis of their primary and
secondary structures, their antimicrobial potential, their effects on host
cells, and the regulation of their expression. Most AMPs are small (12–50
amino-acids), have a positive charge and an amphipathic
structure that enables them to interact with bacterial membranes. AMPs have a higher affinity for microbial
membranes compared to the membranes of host cells and therefore preferentially lyse the pathogenic, microorganisms31,32,33.
9.3 SURGICAL BURN WOUND TREATMENT
9.3.1 Escharotomy
Full-thickness
circumferential and near-circumferential skin burns result in the formation of
a tough, inelastic mass of burnt tissue (eschar). The
eschar, by virtue of this inelasticity, results in
the burn-induced compartment syndrome. This is caused by the accumulation of
extracellular and extravascular fluid within confined
anatomic spaces of the extremities or digits. The excessive fluid causes the
intra-compartmental pressures to increase, resulting in collapse of the
contained vascular and lymphatic structures and, hence, loss of tissue
viability. The capillary closure pressure of 30 mm Hg, also measured as the
compartment pressure, is accepted as that which requires intervention to
prevent tissue death.
Escharotomy is the surgical division of
the nonviable eschar, which allows the cutaneous envelope to become more compliant. Hence, the
underlying tissues have an increased available volume to expand into,
preventing further tissue injury or functional compromise.
Escharotomy is considered an emergent procedure
in burn treatment protocols. However, it rarely needs to be performed in the
emergency department at the time of initial presentation of the severely burned
patient. Advanced ventilation methods allow the patient to be stabilized to
allow for expeditious transfer to the intensive care unit or the surgical
suite, where the procedure can be performed under more controlled
circumstances.
9.3.2 Negative pressure wound therapy
Negative pressure wound therapy (NPWT)
is a relatively new, non-pharmacological, wound management modality. The
vacuum-assisted closure device, introduced by Argenta
and Morykwas, has been used widely in many surgical
services ever since. The result is a well-perfused,
ready-for-graft take, granulation tissue. The NPWT has been used for a broad
indication spectrum ranging from eradication of infection. Its action mechanism
is believed to be stimulation of mitogenesis and
elaboration of growth factors, due to imposed tissue strain, evacuation of
excessive tissue fluid or oedema, and reduction of
bacterial colonization within the wound. The NPWT has been used for a broad
indication spectrum ranging from eradication of infection and decrease of the
depth in cavity wounds to stimulation of granulation tissue in areas with
exposed tendon or bone, in order to choose a simpler reconstruction option at a
later date. Advances in the actual device include smaller size, allowing for
portable units for home use, increased ability to remove large amounts of
fluid, in the wound for continuous irrigation, refinements in the foam with
more consistent pore sizes, different sponge materials including silver, and
increased safety and alarm systems.
Acute wounds are now more
frequently being treated with NPWD closure. In patients with significant comorbidities or other serious injuries, NPWDs can be used
in large soft-tissue injuries, contaminated wounds, and wounds with compromised
tissue. The protocol is altered to include more frequent dressing changes with serial
debridement as necessary. There are several descriptions of the sponge being
placed over vital structures such as vessels, nerves, viscera, or even heart or
lung. Ideally, muscle or soft tissue should be placed between the structure and
the sponge, but if this is not possible Vaseline or silicone mesh should be
used. This allows simplified wound closure in critical patients allowing the
focus to shift to stabilizing the patient for later definitive reconstruction
with flaps34.
9.3.3 Stem cell therapy
The ultimate goal of the
treatment of cutaneous burns and wounds is to restore
the damaged skin both structurally and functionally to its original state.
Recent research advances have shown the great potential of stem cells in
improving the rate and quality of wound healing and regenerating the skin and
its appendages. Stem cell-based therapeutic strategies offer new prospects in
the medical technology for burns and wounds care. Stem cells that have been or
might be used for burns and wound management; the potential role of stem cells
in skin tissue engineering; the wound healing modulation capacity of stem cells
especially bone marrow-derived mesenchymal stem cells
in treating chronic and non- healing wounds35.
9.3.3.1 The Involvement of Stem
Cells in the Wound Healing Process
It is well-known that during the
inflammatory phase of wound healing, blood-borne immuno-competent
cells invade the wound area; recent evidence suggests that bone marrow-derived
stem cells are also recruited into the wound site. This is not completely
surprising, since a small number of hematopoeitic and
mesenchymal stem cells is always present in
peripheral blood. Furthermore, severe injury has been shown to increase the
number of circulating stem cells36,37.
9.3.3.2 Adult stem cells from
bone marrow
The development of therapies
using stem cells in the context on injury and wound healing has primarily
relied on adult stem cells, and especially mesenchymal
stromal cells, also known as mesenchymal
stem cells (MSCs). MSCs are self-renewing and capable of differentiating into
various tissues and cells, including skin cells. MSCs can be isolated from the
patient‘s bone marrow and other tissues such as adipose tissue, nerve tissue,
umbilical cord blood, and dermis38,39. The other important benefit
of MSCs is that even allogeneic MSCs induce little immunoreactivity in the host after local transplantation or
systemic administration. Hence, MSCs have received considerable attention for
modulating wound repair. MSCs have been examined in skin repair and
regeneration after various acute and chronic skin injuries, such as acute incisional and excisional wounds,
diabetic skin ulcers, radiation burns, and thermal burns. Bone marrow-derived
MSCs appear to synthesize higher amounts of collagen and several growth and angiogenic factors, when compared to native dermal
fibroblasts, indicating a potential use in accelerating wound healing40,41,42.
9.3.4 Skin Grafting with Autografts
Wounds that extend deep into the
dermis tend to heal very poorly and slowly because no keratinocytes
remain to reform the epithelium. For such wounds, skin grafting with an autograft is the treatment of choice; since the patient
donates its own tissue, there is no risk of rejection. A dermatome, which is a
surgical instrument that holds a razor-sharp blade parallel to the skin
surface, is used to remove a thin layer of skin from the donor site (most
commonly a conspicuous area such as inner thighs and buttocks) that includes
the full epidermis and portion of the dermis, or what is commonly known a
split-thickness graft. The skin graft is then placed on the wound site. If
large areas need to be covered, such as in cases of extensive burns, the graft
is meshed to enable stretching it over the larger area. The appearance of the
healed wound is best if the graft is thicker (thus including more dermis) and
unmeshed, and those factors are taken into consideration depending on the site
of grafting43. Conversely, healing of the donor site will be more
compromised if a thicker graft is harvested. In general, the thicker the
underlying dermis, the better the graft take, the faster the healing, and the
better the long-term appearance of the healed wound. Donor sites will heal and
can be reharvested, albeit a limited number of times
because the dermis does not regenerate and becomes thinner each time44.
9.3.5 Skin Allografts
and Xenografts
Skin grafting with an autograft may not be immediately possible because of
limited availability of donor tissue. In this instance, wounds may be covered
with allografts, which will serve as temporary
covering since they typically get rejected by the host‘s immune system after a
week. Allografts are harvested from consenting donors
after death and stored frozen in skin banks where they can be used whenever needed.
Allografts provide a barrier function and it is
thought that growth factors released from these grafts have a positive effect
on wound healing until an autograft can be placed
onto the wound. Xenografts made of pig skin have also
been used for the same purpose45.
9.3.6 Uncultured skin autograft
9.3.6.1 Sheet Graft
Sheet Graft is piece of donor
skin, removed from a un-burned area of the body, a process called ‘harvesting
the donor’. The size of the donor skin that is used to patch a burned area is
about the same size as the burn size. The donor sheet is laid over the excised
wound and stapled in place. The disadvantages of sheet grafts are that small
areas of graft might be lost from build up of fluid
(hematoma) under the sheet right after surgery. Sheet grafts also need a larger
donor site than meshed skin. A sheet graft is usually more durability and scars
less46.
9.3.6.2 Meshed skin graft
It is difficult to cover when
there is very large areas of open wounds because of not enough unburned donor skin
availability. So, it is necessary to enlarge donor skin to cover a larger body
surface area. Meshing is a mean to enlarge donor skin. Meshing involves running
the donor skin through a machine that makes small slits, which allows expansion
similar to that in fish netting. In a meshed skin graft, the skin from the
donor site is stretched to allow it to cover an area larger than itself. Most
donor skin is meshed at a 1:1 or 1:2 ratio because the larger the size mesh the
more fragile the graft. The disadvantages of meshing are to be a less durable
graft than a sheet graft. Meshing serves two purposes: it allows blood and body
fluids to drain from under the skin grafts, preventing graft loss, and it
allows the donor skin to cover a greater burned area because it is expanded47.
9.3.6.3 Cultured skin autograft
In massive burns, however, the
available skin donor sites for autografting may be
very limited. This has fostered the development of alternative methods such as autologous cultured skin graft and allograft skin
substitutes as mentioned before. Two main techniques in autogenous
graft for burn treatment include "cultured epithelial autografts;
CEA" and "cell suspension".
9.3.6.4 Cell cultured epithelial
autograft (CEA)
Cultured sheets of human autologous epithelium (CEA = cultured epithelial autografts) still represent the "gold standard"
to resurface large wounds. So, cultured epidermal sheet autografts
became available to complement autologous split
thickness skin grafts in treating major burns or other large wounds. First
harvesting the cell sheets from the culture dishes by trypsin
treatment could damage the anchoring proteins of the cells. This could be one
of the reasons of a mechanical instability of epidermal sheet grafts and
insufficient dermal–epidermal reconstitution that lowers the uptake ratio of
the grafts for a long time after transplantation. Second, epidermal sheet
grafts usually require a long fabrication period. Third, cultured epidermal
sheet grafts composed of fully differentiated keratinocytes
might not exhibit further proliferation of keratinocytes
after transplantation. Fourth, epidermal sheets are only 8–10 cells thick,
which make them fragile and difficult to handle and have high costs of
production. These shortcomings have led to a progressive development of skin
culture techniques and an increased use of suspensions of keratinocytes
single cells being transplanted instead of sheet grafts48.
9.3.7 Cell suspensions
Surprisingly good clinical
results using the technique of "epithelial cell seeding" had been
published by von Mangoldt as early as in 1895 to
treat chronic wounds and wound cavities. In his original description he
harvested epithelial cells or cell clusters by scrap- ing
off superficial epithelium from a patient´s forearm with a surgical blade until
fibrin was exudated from the wound. This mixture was
then applied to wounds. He claimed reduced donor site morbidity and a more
regular aspect of the resurfaced wounds when compared to the method of Reverdin, which was the common method at that time. One of
his key observations was the fact that single cells or cell clusters would
better attach to the wound bed than conventional pieces of skin novel technique
in which they used an aerosol device to spray epithelial cells on wounds in
pigs. They noted that re-epithelialisation, re-growth
of epithelial tissue over a denuded surface, was quicker than in unsprayed
controls. Further advantages of suspension transplantation are to reduce time
needed for culture and the fact that suspended keratinocytes
can be transported from laboratory to patient in small vials, thus reducing the
costs involved and storing frozen in clinic for transplantation. Because the
cells, in culturing and transplanting, are as a suspension rather than a sheet;
the use of enzymes like, Dispase1 can be avoided. Later
this technique was further by combining it with meshed split thickness
skin grafts and faster healing and a
better quality of cells were reorted when they were
sprayed.
9.3.8 Skin tissue engineering
The skin is indeed a complex
structure incorporating a fusion of several different cell types, integrated
within a three dimensional matrix containing both fibrillar
and non-fibrillar elements. To synthesize such a
complex structure by identifying the component parts and to put them together
is neither practical nor realistic. It must be observed, however, that this
integrative strategy has been the major one used in skin tissue engineering
during its less productive phase. Three factors should be considered in the
development of tissue-engineered materials: the safety of the patient, clinical
efficacy and convenience of use. Any cultured cell material carries the risk of
transmitting viral or bacterial infection, and some support materials (such as
bovine collagen and murine feeder cells) may also
have a disease risk. There must be clear evidence that tissue-engineered
materials provide benefit to the patient. Essential characteristics are that it
heals well and has the physical properties of normal skin. To achieve effective
healing, the tissue- engineered products must attach well to the wound bed, be
supported by new vasculature, not be rejected by the immune system and be
capable of self repair throughout a patient’s life. Finally, materials need to
be convenient to use or they will not achieve clinical uptake. Most
tissue-engineered skin is created by expanding skin cells in the laboratory and
used to restore barrier function or to initiate wound healing. There are those
that replace the epidermal layer only, those that provide a dermal substitute,
and a small number that provide both. In some clinical conditions (such as
non-healing ulcers and superficial burns) simply transferring laboratory
expanded cells can benefit patients, but the treatment of major full-thickness
burns requires the replacement of both dermis and epidermis. There are four
major challenges in this field: improving safety, finding a substitute for
split-thickness grafts, improving angiogenesis in replacement tissue once it
has been grafted to the wound bed, and improving ease
of use. Although progress has been made in developing new treatments for burn
victims, including skin grafting and artificial skin technologies; these
cultured skin grafts do not have hair follicles, sweat glands and other
features of normal skin. The result is thin, inflexible skin (which hampers
mobility of joints), and skin that dramatically differs from the remaining
healthy skin. A promising alternative to these techniques is stem cell-based
therapy49.
9.3.9 Hyperbaric Oxygen Therapy
Hyperbaric oxygen therapy (HBOT)
is the use of 100% oxygen at pressures greater than atmospheric pressure. Today
several approved applications and indications exist for HBOT. HBOT has been
successfully used as adjunctive therapy for wound healing. HBOT is also
indicated for infected wounds like clostridial-myonecrosis,
necrotising soft tissue infections, Fournier's
gangrene, as also for traumatic wounds, crush injury, compartment syndrome,
compromised skin grafts and flaps and thermal burns. Another major area of
application of HBOT is radiation-induced wounds, specifically osteo-radionecrosis of mandible, radiation cystitis and
radiation proctitis. HBOT should be considered in
these situations as an essential part of the overall management strategy for
the treating surgeon.
The mechanism of action of
hyperbaric oxygen is not clearly understood. Initial theories focused on
increases in oxygen availability at the tissue level. The increased atmospheric
pressure increases arterial oxygen pressure (PaO2), which in turn causes
vasoconstriction. This vasoconstriction on the arterial end reduces capillary
pressure, which promotes fluid absorption into the venous system thereby
reducing oedema, as well as causing an increase in
hyper-oxygenated plasma to the tissues. This effect typically lasts for several
hours after the treatment has finished. Tissue repair processes such as
collagen elongation and deposition and bacterial killing by macrophages are
dependent upon oxygen, so increased levels, especially in wound areas that
already have impaired perfusion, serve to facilitate wound healing50.
9.3.10 Growth Factors and
Biologic Wound Products
Biologic wound products have
been an area of tremendous growth as our understanding of the details of the
wound healing response has increased. In normal wound healing there is an
orderly, predictable sequence passing through the inflammatory, proliferation,
and remodeling/ maturation phases. This process is driven by numerous cellular
mediators including eicosanoids, cytokines, nitric
oxide, and various growth factors. The field of biologic wound products aims to
accelerate healing by augmenting or modulating these inflammatory mediators. Eicosanoids are arachadonic acid
metabolites including prostaglandins, prostacyclins, thromboxane, and leukotriene.
They primarily affect the early stages of wound healing including initial
vasoconstriction and later vasodilation, vascular
permeability, and inflammatory cell chemotaxis and
adhesion. The most well-known is prostaglandin E1 which inhibits platelet and neutrophil activation, reduces blood viscosity, stimulates
tissue plasminogen activator production, and causes vasodilation by relaxing vascular smooth muscle. Cytokines
regulate inflammation by influencing hematopoietic cells and include chemokine, lymphokines, monokines, interleukins, colony-stimulating factors, and interferons. Interleukin-1, stimulates most cells in the
wound environment. Granulocyte/macrophage colony-stimulating factor (GM-CSF)
has been most extensively studied. Its effects are to stimulate neutrophils, macrophages, keratinocytes,
and fibroblasts and increase VEGF production, rendering it a very promising
molecule in wound healing. Growth factors stimulate mainly fibroblasts and keratinocytes via trans-membrane glycoproteins.
They are divided into five super-families, the most known being the
platelet-derived growth factors. The rhPDGF group
showed a statistically significant higher percentage of patients that achieved
wound healing, 48% versus 25%, as well as a greater reduction in wound size
(Table 6). It is the only current FDA-approved product in the growth factor
family51.
10.
CONCLUSION:
Wounds are one of the most harmful
and complex physical injuries. They often happen unexpectedly and have the
potential to cause death, lifelong disfigurement and dysfunction. The challenge
of surviving a major woundable depends on skin repair. In recent years, the
field of wound management has shown rapid advances. This review focuses on
treatment and new advancements that have been used in recent years for the
proper healing of the wounds. The effective management of wounds will reduce
the number of complications and allow rapid return to normal function. The
wound should be protected with dressings that are chosen according to the stage
of healing. Recently, skin grafting has evolved from the initial auto-graft and
allograft preparations to biosynthetic and tissue-engineered living skin
replacements. Tissue engineering now provides the clinician with more
therapeutic options and more challenges. Consequently, it is essential to
critically analyze the clinical needs of skin repair and understand skin
replacement in terms of the availability, compatibility, safety and durability.
11. ACKNOWLEDGEMENT:
The authors are thankful to Director,
University Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur (C.G.) for providing necessary
facilities relating to present work and UGC-MRP 41-748/2012 (SR); CGCOST
(CCOST/650/2011); UGC-RAF- 30-5/2011 (SA-II) for financial assistance for the
studies.
Table 6: Growth factors involved
in wound healing52:
|
Growth factor |
Abbreviation |
Main origins |
Effects |
|
Epidermal growth factor |
EGF |
Activated macrophages |
Keratinocyte and fibroblast mitogen Granulation tissue formation |
|
Transforming growth factor-α |
TGF-α |
Activated macrophages T-lymphocytes Keratinocytes |
Hepatocyte and
epithelial cell proliferation Expression of antimicrobial peptides |
|
Hepatocyte
growth factor |
HGF |
Epithelial and endothelial cell proliferation Hepatocyte motility |
|
|
Vascular endothelial growth factor |
VEGF |
Mesenchymal cells |
Vascular permeability Endothelial cell proliferation |
|
Platelet derived growth factor |
PDGF |
Platelets Macrophages Endothelial cells Smooth muscle cells Keratinocytes |
Granulocyte, macrophage, fibroblast and smooth muscle cell chemotaxis Fibroblast,
endothelial cell and smooth muscle cell proliferation |
|
Granulocyte,
macrophage, lymphocyte, fibroblast and smooth muscle cell chemotaxis |
|||
1.
Sterling JP, Heimbach DM, Gibran
NS, Management of the Burn Wound, ACS
Surgery, 2010.
9.
Balasubramani M, Kumar TR, Babu M, Skin substitutes: a review, Burns, 2001, 27,
34-544.
13.
Atiyeh BS, Gunn SW,
Hayek SN, State of the art in burn treatment, World J Surg, 2005.
17.
Sarabhai S, Recent Advances in Topical Wound Care, Indian
J PlastSurg, 2012.
18.
Camron AM, Ruzehazi N &Cowin AJ, Burn
wound Management: a surgical
Perspective, 2010.
20.
Leon- VJ, Jeschke R, Herndon DN,
Topical Mnagement of Facial burn, Burns 2008.
25.
David G Greenhalgh, Topical
antimicrobial agents for burn wound, Elesvierinc,
2009.
26.
Gelmetti C, Local
antibiotics in dermatology, Dermatol Ther, 2008.
27.
Lio PA, Raye ET, Topical antibacterial agents, Infect Dis Clin North, 2009.
29.
Schmidtchen A, Malmsten M, Improved antimicrobial peptides, 2009.
30.
Bhat S, Milner S,
Antimicrobial peptides in burns and wounds, Curr
Protein Pept Sci, 2007.
31.
Bhat S, Milner S,
Antimicrobial peptides in burns and wounds, Curr
Protein Pept Sci, 2007.
32.
Schmidtchen A, Malmsten M, Improved antimicrobial peptides, 2009.
36.
Cha J, Falanga V, Stem cells in cutaneous wound healing, Clin Dermatol, 2007.
44.
Church D, Elsayed S, Reid O,
Burn Wound Infection, Clin Microbiol
Rev, 2006.
47.
Pascal M and Anthony C D, Mechanism involved in wound
healing, The biomedical scientist, 2008.